BioCentury
ARTICLE | Clinical News

Invocana canagliflozin regulatory update

December 10, 2012 8:00 AM UTC

FDA's Endocrinologic and Metabolic Drugs Advisory Committee will meet on Jan. 10, 2013, to discuss an NDA from Johnson & Johnson for Invocana canagliflozin to treat Type II diabetes. J&J submitted the...